The Cell Adhesion Molecule “CAR” and Sialic Acid on Human Erythrocytes Influence Adenovirus In Vivo Biodistribution
about
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsDevelopment of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based ConstructsViruses and sialic acids: rules of engagementCircumventing antivector immunity: potential use of nonhuman adenoviral vectorsCAR-associated vesicular transport of an adenovirus in motor neuron axonsStructural basis for sialic acid-mediated self-recognition by complement factor HInsights into Adenovirus Uncoating from Interactions with Integrins and Mediators of Host ImmunityIs there a risk of zoonotic disease due to adenoviruses?Analysis of adenoviral attachment to human platelets.The influence of innate and pre-existing immunity on adenovirus therapyInfection and killing of multiple myeloma by adenovirusesBiodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectorsBiological challenges and technological opportunities for respiratory syncytial virus vaccine development.Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated virus 4Human adenovirus 52 uses sialic acid-containing glycoproteins and the coxsackie and adenovirus receptor for binding to target cellsCrystal structure of the fibre head domain of the Atadenovirus Snake Adenovirus 1Species D adenoviruses as oncolytics against B-cell cancers.Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivoIncorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer TherapiesGene therapy for cancer: present status and future perspectiveTrichodysplasia spinulosa-Associated Polyomavirus Uses a Displaced Binding Site on VP1 to Engage Sialylated GlycolipidsCoagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus)A Siglec-like sialic-acid-binding motif revealed in an adenovirus capsid proteinAmphiphilic core-shell nanoparticles containing dense polyethyleneimine shells for efficient delivery of microRNA to Kupffer cells.Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous deliveryIdentification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies.Polymer-enhanced adenoviral transduction of CAR-negative bladder cancer cells.Strategies to overcome host immunity to adenovirus vectors in vaccine development.An adenovirus traffic update: from receptor engagement to the nuclear pore.Manipulation of adenovirus interactions with host factors for gene therapy applications.Latest insights on adenovirus structure and assembly.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-negative cells.CAR mediates efficient tumor engraftment of mesenchymal type lung cancer cells.Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits.Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid.A comparative review of viral entry and attachment during large and giant dsDNA virus infections.Adenovirus coxsackie adenovirus receptor-mediated binding to human erythrocytes does not preclude systemic transduction.Human coagulation factor X-adenovirus type 5 complexes poorly stimulate an innate immune response in human mononuclear phagocytes.
P2860
Q26776553-7DDBBC54-25AB-4C83-B3BB-4C97C2D89F7EQ26782083-DA71DF8D-AFD5-4041-91AD-928F9CAF135AQ26852325-337CA1B4-1D67-4743-9353-21AB3ECBC52AQ26995655-09D2828C-3793-43D8-B0BD-7FD0A4C1947DQ27316954-6B3D7AFC-0ED7-4879-82E1-D10526C5FBA4Q27696183-DB64906B-9E73-4242-93DA-53655830F208Q28078297-35008B43-032F-4C21-8B35-B368E5FAED7BQ28080712-EEB40DA3-1762-4070-9522-CE765347670DQ33383309-0C8341EF-5B04-4AD6-B88D-3EAB0B485B2FQ33655401-4A77539A-17BF-47A4-BE5F-2ABFCFD53C25Q33691833-9320996A-5BF0-42A7-8B0C-1E90BED840ADQ34282191-18D2F53D-9BFF-45BF-B6B4-390119CC7C7FQ34504791-7A4C9636-A0F7-449D-8F90-CE8E632D711DQ34997974-7E75442D-95C6-4B26-BDE3-AA4D3CC779AEQ35104823-3C173676-9241-4568-A4C6-394E26CADC1FQ35500187-1CAC8EA7-D28A-4C90-932E-8591EB3957C2Q35511348-AF5F3716-EC7A-479B-88D1-0395FFE522E9Q35557004-AC9979FA-6BAF-40D2-ABE2-370DC69C101EQ35641791-F21C8898-646C-49CC-A147-7D63ADF87920Q35673900-25CF306D-86F0-4590-8B7E-BE3292F55814Q35753796-37404707-61AA-418A-9D4D-BDA76F1AB9FAQ36055718-7CB50BCB-C1DC-48AF-ABBD-D771DE3059E5Q36056053-04D0CA9F-3EFC-4E24-810E-0F12CCD12D06Q36065583-62601927-BF33-46C2-9578-4A03E41F35B3Q36445557-53E38C3C-0175-4020-83D4-F6A788A3C9C7Q37291653-4A2859C8-389C-4C35-92E0-A64E677AB484Q37317439-0BBC99A9-E5C7-4F22-907C-BB56705F4BE1Q37376339-6421ADF2-266C-4BA5-B0F3-E60B512E2519Q37503253-8B045960-4FA8-4636-A922-7D6BA6A1D769Q37848821-57A789D5-54F1-4328-81EB-80FD8107D833Q37984486-6C239087-D060-4F02-905A-54754457DDDBQ38023422-14B7A978-26D8-4C7A-A52A-EE2F855AA3F1Q38614156-C6F73528-B504-48FC-B842-9257999604A9Q39682767-1797681D-689E-4DCC-BBA9-F2FAD42CAF67Q39841138-2BFB0AC4-DB33-42F3-9C9A-44851FB90CE4Q39891887-8B6A264F-9546-45FD-8AA4-A844B802F82FQ40053564-340B05D5-4522-417B-AA3D-E586353A15E0Q40060063-4C0343BC-4D57-4341-8274-4F7270453339Q40526707-1DB61B33-DF45-4358-B7C3-4CCA31AFEC99Q41650213-89E6EE62-104D-416D-8637-40FF1875B8CD
P2860
The Cell Adhesion Molecule “CAR” and Sialic Acid on Human Erythrocytes Influence Adenovirus In Vivo Biodistribution
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The Cell Adhesion Molecule “CA ...... ovirus In Vivo Biodistribution
@ast
The Cell Adhesion Molecule “CA ...... ovirus In Vivo Biodistribution
@en
The Cell Adhesion Molecule “CA ...... ovirus In Vivo Biodistribution
@nl
type
label
The Cell Adhesion Molecule “CA ...... ovirus In Vivo Biodistribution
@ast
The Cell Adhesion Molecule “CA ...... ovirus In Vivo Biodistribution
@en
The Cell Adhesion Molecule “CA ...... ovirus In Vivo Biodistribution
@nl
altLabel
The cell adhesion molecule "CA ...... ovirus in vivo biodistribution
@en
prefLabel
The Cell Adhesion Molecule “CA ...... ovirus In Vivo Biodistribution
@ast
The Cell Adhesion Molecule “CA ...... ovirus In Vivo Biodistribution
@en
The Cell Adhesion Molecule “CA ...... ovirus In Vivo Biodistribution
@nl
P2093
P2860
P50
P3181
P1433
P1476
The cell adhesion molecule "CA ...... ovirus in vivo biodistribution
@en
P2093
Claire Hippert
Daniel Henaff
Franck Mennechet
Hanna Dreja
Hugues Lortat-Jacob
Matthieu Perreau
Olivier Billet
Robert W Finberg
Sandy Ibanes
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1000277
P407
P50
P577
2009-01-02T00:00:00Z